Clinical Trial Update: Bumetanide in Patients With Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of bumetanide in Alzheimer's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• BUMETANIDE (bumetanide)

Snippet

Sponsor: Stanford University | Conditions: Alzheimer Disease | Phase 2 | Status: RECRUITING